vancomycin has been researched along with ketamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Wu, J | 1 |
| Aguirre, CA; English, BK; Lazar, L; Meals, E; Rayburn, MS; Shapley, RK; Spentzas, T; Walker, BS | 1 |
| Armstrong, DW; Folprechtová, D; Kalíková, K; Kozlov, O; Schmid, MG; Tesařová, E | 1 |
1 review(s) available for vancomycin and ketamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for vancomycin and ketamine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Deep sedation with intravenous infusion of combined propofol and ketamine during dressing changes and whirlpool bath in patients with severe epidermolysis bullosa.
Topics: Adolescent; Analgesics; Anesthetics, Intravenous; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bandages; Drug Therapy, Combination; Epidermolysis Bullosa; Female; Humans; Hydrotherapy; Infusions, Intravenous; Ketamine; Male; Pain; Propofol; Rifampin; Severity of Illness Index; Vancomycin; Wound Infection | 2007 |
Ketamine inhibits tumor necrosis factor secretion by RAW264.7 murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant Staphylococcus aureus.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-Bacterial Agents; Cell Line; Daptomycin; Dizocilpine Maleate; Drug Synergism; Ketamine; Macrophage Activation; Macrophages; Methicillin-Resistant Staphylococcus aureus; Mice; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Time Factors; Tumor Necrosis Factor-alpha; Vancomycin | 2011 |
Enantioselective potential of teicoplanin- and vancomycin-based superficially porous particles-packed columns for supercritical fluid chromatography.
Topics: Alkaloids; Chromatography, Supercritical Fluid; Hydrogen Bonding; Ketamine; Phytoalexins; Porosity; Sesquiterpenes; Solvents; Stereoisomerism; Teicoplanin; Trifluoroacetic Acid; Vancomycin | 2020 |